Study guide

Arrhythmias and conduction emergencies

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Arrhythmias and conduction emergencies

Key Takeaways Explain This Topic AI

Haemodynamically unstable AF requires urgent synchronised cardioversion.

CHA2DS2-VA assesses stroke risk without including sex as a point.

A bleeding score alone should not deny indicated anticoagulation.

Last updated: October 2026

  • Cardiac Arrhythmias: Tachyarrhythmias
  • Atrial Fibrillation (AF)

Haemodynamic Instability : Patients with AF presenting with shock, acute pulmonary oedema, ongoing myocardial ischaemia, or syncope require immediate synchronized direct current cardioversion (DCCV) .

Rate vs. Rhythm Control : In stable patients, initial rate control is preferred. First-line agents include oral or intravenous beta-blockers (e.g., metoprolol, bisoprolol) or non-dihydropyridine calcium channel blockers (diltiazem, verapamil). Non-dihydropyridine CCBs are contraindicated in HFrEF due to their negative inotropic effect; beta-blockers or digoxin are utilized instead.

AF stroke prevention: Australian guidance uses CHA2DS2-VA, without a sex-category point. Anticoagulation is recommended at a score of at least 2, considered at 1 after discussion, and generally unnecessary at 0. Assess bleeding risks and modify them; do not use a bleeding score alone to deny indicated anticoagulation.

Congestive HF (1), Hypertension (1), Age ≥ 75 \ge 75 ≥ 75 (2), Diabetes (1), Stroke / TIA / Thromboembolism (2), Vascular disease (1), Age 65–74 (1).

Threshold : Oral anticoagulation is strongly recommended for a score ≥ 2 \ge 2 ≥ 2 in men or ≥ 3 \ge 3 ≥ 3 in women, and should be considered for a score of 1 in men or 2 in women.

Direct Oral Anticoagulants (DOACs) : Apixaban ( 5 mg 5\text{ mg} 5 mg BD), rivaroxaban ( 20 mg 20\text{ mg} 20 mg daily), or dabigatran ( 150 mg 150\text{ mg} 150 mg BD) are preferred over warfarin due to lower rates of intracranial haemorrhage and superior convenience without routine INR monitoring. Warfarin remains mandatory exclusively for patients with mechanical prosthetic heart valves or moderate-to-severe rheumatic mitral stenosis .

Supraventricular Tachycardia (SVT)

Narrow-complex regular tachycardia most frequently represents Atrioventricular Nodal Re-entrant Tachycardia (AVNRT) or Atrioventricular Re-entrant Tachycardia (AVRT).

First-Line : Modified Valsalva manoeuvre (strain in semi-recumbent position for 15 seconds, followed immediately by supine repositioning with 45-degree passive leg elevation for 15 seconds), which achieves cardioversion in over 40% of cases.

Second-Line : Rapid intravenous adenosine via a large-bore antecubital vein ( 6 mg 6\text{ mg} 6 mg rapid bolus followed by immediate saline flush; if unsuccessful, administer 12 mg 12\text{ mg} 12 mg , then a second 12 mg 12\text{ mg} 12 mg dose). Warn the patient of transient flushing, dyspnoea, and impending doom. Adenosine is contraindicated in severe asthma (may trigger refractory bronchospasm); intravenous verapamil is preferred in asthmatic patients.

Ventricular Arrhythmias & Resuscitation

Pulseless VT / Ventricular Fibrillation (VF) : Follow the Australian Resuscitation Council (ARC) Advanced Life Support (ALS) algorithm:

Immediate uninterrupted cardiopulmonary resuscitation (CPR) at a 30:2 ratio.

Defibrillation: Early unsynchronized high-energy biphasic shock ( 200 J 200\text{ J} 200 J ). Resume CPR immediately for 2 minutes before rhythm recheck.

Adrenaline: 1 mg 1\text{ mg} 1 mg IV administered after the 2nd shock, and repeated every second cycle (every 3 to 5 minutes).

Amiodarone: 300 mg 300\text{ mg} 300 mg IV bolus administered after the 3rd shock; an additional 150 mg 150\text{ mg} 150 mg IV may be given after the 5th shock.

Haemodynamically Stable Sustained Monomorphic VT : Administer intravenous amiodarone ( 300 mg 300\text{ mg} 300 mg infusion over 20 to 60 minutes) or perform elective synchronized DCCV.

Bradyarrhythmias and Conduction Disorders

Bradyarrhythmias originate from sinus node dysfunction or impaired conduction through the atrioventricular node and infranodal His-Purkinje network.

Clinical comparison: AV Block Classification and Pacemaker Indications

First-Degree AV Block : Anatomic Site of Block: AV Node (usually); ECG Features: Constant PR interval > 200 ms > 200\text{ ms} > 200 ms ; all P waves conducted; Clinical Prognosis: Benign; excellent prognosis; Definitive Pacemaker Indication: No (unless PR > 300 ms > 300\text{ ms} > 300 ms causing pacemaker syndrome)

Second-Degree Mobitz I (Wenckebach) : Anatomic Site of Block: AV Node; ECG Features: Progressive PR lengthening until a P wave fails to conduct; Clinical Prognosis: Low risk of progression to asystole; Definitive Pacemaker Indication: Only if symptomatic bradycardia is documented

Second-Degree Mobitz II : Anatomic Site of Block: Infranodal (Bundle of His / Purkinje); ECG Features: Constant PR interval with intermittent non-conducted P waves; Clinical Prognosis: High risk of progression to complete heart block; Definitive Pacemaker Indication: Yes , absolute indication for permanent pacemaker

Complete AV block: Atria and ventricles activate independently. Escape rhythm width and rate help localise the block, but not every complete block is infranodal. Unstable patients need urgent pacing support; investigate ischaemia, medicines and metabolic causes.

Acute Bradycardia Management

Unstable Features : Hypotension, altered conscious state, syncope, diaphoresis, or heart failure.

First-Line Pharmacotherapy : Intravenous atropine ( 500 mcg 500\text{ mcg} 500 mcg IV every 3 to 5 minutes up to a maximum of 3 mg 3\text{ mg} 3 mg ). Note: Atropine is effective only for nodal blocks and is ineffective in infranodal Mobitz II or complete heart block with wide escape complexes.

Second-Line / Bridging : Intravenous isoprenaline infusion or adrenaline infusion ( 2 to 10 mcg/min 2\text{ to }10\text{ mcg/min} 2 to 10 mcg/min ). If pharmacological measures fail, initiate emergency transcutaneous pacing with appropriate sedation/analgesia as a bridge to emergency transvenous temporary pacing .

Arrhythmia review example

A stable AF patient with renal impairment needs dose-appropriate anticoagulant selection and medication review, not a standard full dose copied from a table. Explain bleeding signs, adherence and what to do before a procedure. A different patient with syncope, hypotension and complete block requires immediate pacing assessment. These decisions separate long-term stroke prevention from an unstable electrical emergency; neither a normal oxygen saturation nor a short-lived symptom resolution removes the need to assess the relevant risk.

Primary references (checked 7 October 2026): Heart Foundation AF resources .